PNC Managed Account Solutions’s Novo Nordisk NVO Stock Holding History

PNC Managed Account Solutions’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$117K	Buy	+2,798	New	+$108K	0.02%	286

Other funds holding NVO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

EHC

Everett Harris & Co Los Angeles, California $7.77B AUM 9.43% 1-Year Est. Return

PNC Managed Account Solutions's NVO Position: Q2 2021 in Review

PNC Managed Account Solutions opened a new position in Novo Nordisk (NVO) in Q2 2021: 2,798 shares worth $117K. The stake represents 0.02% of the portfolio and ranks #286 among its holdings.

735 funds tracked by Wall St. Rank hold NVO as of Q2 2021.

PNC Managed Account Solutions held 2,798 shares of Novo Nordisk worth $117K as of Q2 2021.
Novo Nordisk was a new PNC Managed Account Solutions position in Q2 2021.
Novo Nordisk made up 0.02% of PNC Managed Account Solutions's portfolio in Q2 2021, its #286 holding.
735 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2021.

Based on PNC Managed Account Solutions's 13F filing for Q2 2021, filed 6 Aug 2021.